Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis.

Christy J KhouderchahMadeleine OchsMatthew PiankoZahra MahmoudjafariJordan SnyderIman AhmedErica CampagnaroVictoria R Nachar

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)

Due to the complexity of this patient population, close monitoring and multidisciplinary care are crucial. This approach is essential for effectively managing MM patients with renal dysfunction and for exploring novel treatment options.

Keyphrases

multiple myeloma
quality improvement
healthcare
palliative care
case report
peritoneal dialysis
end stage renal disease
chronic kidney disease
oxidative stress
pain management
affordable care act
chronic pain